FDA Commissioner Scott Gottlieb issued a statement Tuesday highlighting what the agency would do with the increased funds provided in the administration’s proposed budget for FY 2019. Source: Drug Industry…
The company plans to submit for regulatory approvals pending additional data from the ongoing Taltz development program later this year. Source: BioSpace
Teva and Mylan are looking over their shoulders this morning after the FDA gave Novartis and Momenta the green light for their Copaxone copycat drug. Source: BioSpace
The company plans to add approximately 100 positions at the Center by 2020. Source: BioSpace
The FDA approved Vertex's Symdeko for cystic fibrosis in patients ages 12 and older with two copies of the F508del mutation. Source: BioSpace
The acquisition will strengthen Charles River's position as a global early-stage CRO, expanding its client base and service portfolio. Source: BioSpace
Bob Hugin announced his campaign on Monday in an email. Source: BioSpace
The Branford, CT-based company was founded in 2017 and plans to list on the Nasdaq under the symbol BTAI. Source: BioSpace
That announcement is a big change in the way Purdue has aggressively marketed OxyContin in the past. Source: BioSpace
AmerisourceBergen is one of the biggest drug distributors in the U.S. Source: BioSpace